NumerixS Investment Technologies’s Pacira BioSciences PCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-6,000
Closed -$201K 1238
2020
Q1
$201K Buy
6,000
+5,399
+898% +$224K 0.1% 243
2019
Q4
$27K Sell
601
-899
-60% -$38.2K 0.01% 910
2019
Q3
$57K Sell
1,500
-1,900
-56% -$75.8K 0.01% 698
2019
Q2
$148K Sell
3,400
-5,006
-60% -$213K 0.04% 485
2019
Q1
$320K Buy
8,406
+5,406
+180% +$211K 0.04% 514
2018
Q4
$128K Sell
3,000
-1,700
-36% -$79.4K 0.04% 486
2018
Q3
$227K Buy
+4,700
New +$203K 0.04% 538
2018
Q1
Sell
-4,300
Closed -$196K 1224
2017
Q4
$196K Buy
4,300
+2,000
+87% +$79.3K 0.04% 466
2017
Q3
$86K Buy
+2,300
New +$92.6K 0.02% 798
2016
Q3
Sell
-10,423
Closed -$352K 1260
2016
Q2
$352K Buy
+10,423
New +$512K 0.05% 528
2015
Q4
Sell
-38,390
Closed -$1.58M 856
2015
Q3
$1.58M Buy
38,390
+12,990
+51% +$796K 0.18% 128
2015
Q2
$1.8M Buy
25,400
+14,800
+140% +$1.17M 0.24% 105
2015
Q1
$942K Buy
10,600
+5,400
+104% +$548K 0.17% 157
2014
Q4
$461K Buy
+5,200
New +$492K 0.16% 196

Other funds holding PCRX